Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies
figureposted on 2021-02-16, 08:37 authored by Adis journals on behalf of, Thomas M. Caparrotta, Jack B. Templeton, Thomas A. Clay, Sarah H. Wild, Rebecca M. Reynolds, David J. Webb, Helen M. Colhoun
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.